— Know what they know.
Not Investment Advice
Also trades as: VLA.PA (PAR) · $vol 2M · VALN (NASDAQ) · $vol 0M · 0OB3.L (LSE) · $vol 0M · VLAP.PA (PAR)

INRLF OTC

Valneva SE
1W: +0.0% 1M: +2.4% 3M: +28.6% YTD: -16.8% 1Y: -31.5% 3Y: -73.8% 5Y: +13.5%
$3.37
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 57 · $639.1M mcap · 170M float · 0.0002% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
-$53M +21.3% ▲
Capital Expenditures
$4M +72.7% ▲
5Y CAGR: -25.5%
Free Cash Flow
-$57M +31.4% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$59M -238.9% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$73M-$143M-$101M-$12M-$115M
Depreciation & Amort.$14M$21M$18M$20M$22M
Stock-Based Comp.$15M-$9M$5M$8M$10M
Change in Working Capital$36M-$146M-$145M-$12M-$148K
Other Non-Cash Items$82M$33M$18M-$72M$30M
Operating Cash Flow$77M-$245M-$203M-$67M-$53M
— Investing Activities —
Capital Expenditures-$93M-$29M-$14M-$14M-$4M
Acquisitions (Net)$0$8K-$11M$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$841K
Other Investing$55K$260K$5M$91M$2M
Investing Cash Flow-$93M-$29M-$21M$77M-$2M
— Financing Activities —
Net Debt Issuance-$4M$34M$76M-$6M$61K
Stock Repurchased$0$0-$240K$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$8M-$9M-$13M-$20M-$31M
Financing Cash Flow$155M$215M$63M$31M-$621K
Net Change in Cash$142M-$57M-$160M$42M-$59M
Cash End of Period$347M$289M$126M$168M$110M
Free Cash Flow-$16M-$275M-$217M-$84M-$57M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms